Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways

Journal of Immunology

Volumn 162, Issue 5, 1999, Pages 2946-2955

  Sabroe, Ian ^a,c   Hartnell, Adele ^a   Jopling, Louise A ^a   Bel, Sandra ^a,d   Ponath, Paul D ^b   Pease, James E ^a   Collins, Paul D ^a   Williams, Timothy J ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHEMOKINE; CHEMOKINE RECEPTOR; EOTAXIN; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; RANTES;

ARTICLE; ASTHMA; AUTOFLUORESCENCE; CELL SHAPE; CELL STIMULATION; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; EOSINOPHIL; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKOCYTE MIGRATION; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

EID: 0033105639     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.162.5.2946     Document Type: Article

References (55)

1. Spry, C. J. F., and P.-C. Tai. 1989. Eosinophils and tissue injury. In Eosinophils in Asthma, Vol. 4. J. Morley, and I. Colditz, eds. Academic Press, Harcourt Brace Jovanovich, London, p. 185.
2. Kroegel, C., J.-C. Virchow, Jr., W. Luttmann, C. Walker, and J. A. Warner. 1994. Pulmonary immune cells in health and disease: the eosinophil leucocyte (part I). Eur. Respir. J. 7:519.
3. Jose, P. J., D. A. Griffiths-Johnson, P. D. Collins, D. T. Walsh, R. Moqbel, N. F. Totty, O. Truong, J. J. Hsuan, and T. J. Williams. 1994. Eotaxin: a potent chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. J. Exp. Med. 179:881.
4. Humbles, A. A., D. M. Conroy, S. Marleau, S. M. Rankin, R. T. Palframan, A. E. I. Proudfoot, T. N. C. Wells, D. Li. P. K. Jeffery, D. A. Griffiths-Johnson, et al. 1997. Kinetics of cotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J. Exp. Med. 186:601.
5. Collins, P. D., S. Marleau, D. A. Griffiths-Johnson, P. J. Jose, and T. J. Williams. 1995. Cooperation between interleukin-5 and the chemokine Eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169.
6. Palframan, R. T., P. D. Collins, T. J. Williams, and S. M. Rankin. 1998. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 91:2240.
7. Ponath, P. D., S. Qin, D. J. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J.-A. Gonzalo, W. Newman, et al. 1996. Cloning of the human eosinophil chemoattractant, eotaxin: expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:604.
8. Garcia-Zepeda, E. A., M. E. Rothenberg, R. T. Ownbey, J. Celestin, P. Leder, and A. D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:449.
9. Lamkhioued, B., P. M. Renzi, S. Abi-Younes, E. A. Garcia-Zepeda, Z. Allakhverdi, O. Ghaffar, M. D. Rothenberg, A. D. Luster, and Q. Hamid. 1997. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J. Immunol. 159:4593.
10. Ying, S., D. S. Robinson, Q. Meng, J. Rottman, R. Kennedy, D. J. Ringler, C. R. Mackay, B. L. Daugherty, M. S. Springer, S. R. Durham, et al. 1997. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma: association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur. J. Immunol. 27:3507.
11. White, J. R., C. Imburgia, E. Dul, E. Appelbaum, K. O'Donnell, D. J. O'Shaughnessy, M. Brawner, J. Fornwald, J. Adamou, N. A. Elshourbagy, et al. 1997. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J. Leukocyte Biol. 62:667.
12. Forssmann, U., M. Uguccioni, P. Loetscher, C. A. Dahinden, H. Langen, M. Thelen, and M. Baggiolini. 1997. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like cotaxin on human eosinophil and basophil leukocytes. J. Exp. Med. 185:2171.
13. Ponath, P. D., S. Qin, T. W. Post, J. Wang, L. Wu, N. P. Gerard, W. Newman, C. Gerard, and C. R. Mackay. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183:2437.
14. Baggiolini, M., and C. A. Dahinden, 1994. CC chemokines in allergic inflammation. Immunol. Today 15:127.
15. Uguccioni, M., P. Loetscher, U. Forssmann, B. Dewald, H. Li, S. H. Lima, Y. Li, B. Kreider, G. Garotta, M. Thelen, et al. 1996. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J. Exp. Med. 183-2379.
16. Garcia-Zepeda, E. A., C. Combadiere, M. E. Rothenberg, M. N. Sarafi, F. Lavigne, Q. Hamid, P. M. Murphy, and A. D. Luster. 1996. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophits induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J. Immunol. 157:5613.
17. Slellato, C., P. Collins, H. Li, J. White, P. D. Ponath, W. Newman, D. Soler, G. LaRosa, L. M. Schwiebert, C. Bickel, et al. 1997. Production of the novel CC chemokine MCP-4 by airway cells and comparison of its biological activity to other CC chemokines. J. Clin. Invest. 99:926.
18. Daugherty, B. L., S. J. Siciliano, J. A. DeMartino, L. Malkowitz, A. Sirotina, and M. S. Springer. 1996. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183:2349.
19. Sabroe, I., D. M. Conroy, N. P. Gerard, Y. Li, P. D. Collins, T. W. Post, P. J. Jose, T. J. Williams, C. J. Gerard, and P. D. Ponath. 1998. Cloning and characterisation of the guinea pig eosinophil eotaxin receptor, CCR3: blockade using a monoclonal antibody in vivo. J. Immunol. 161:6139.
20. Teixeira, M. M., T. N. Wells, N. W. Lukacs, A. E. Proudfoot, S. L. Kunkel, T. J. Williams, and P. G. Hellewell. 1997. Chemokine-induced eosinophil recruitment: evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J. Clin. Invest. 100:1657.
21. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the cotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005.
22. Gerber, B. O., M. P. Zanni, M. Uguccioni, M. Loelscher, C. R. Mackay, W. J. Pichler, N. Yawalkar, M. Baggiolini, and B. Moser. 1997. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr. Biol. 7:836.
23. Sallusto, F., D. Lenig, C. R. Mackay, and A. Lanzavecchia. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875.
24. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, et al. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129.
25. Gura, T. 1996. Chemokines take center stage in inflammatory ills. Science 272:954.
26. Wolpe, S. D., G. Davetelis, B. Sherry, B. Beutler, D. G. Hesse, H. T. Nguyen, L. L. Moldawer, C. F. Nathan, S. F. Lowry, and A. Cerami. 1988. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemotactic properties. J. Exp. Med. 167:570.
27. Uguccioni, M., M. D'Apuzzo, M. Loetscher, B. Dewald, and M. Baggiolini. 1995. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α, and MIP-1β on human monocytes. Eur. J. Immunol. 25:64.
28. Proudfoot, A. E. I., C. A. Power, A. Hoogewerf, M.-O. Montjovent, F. Borlat, and T. N. C. Wells. 1995. Characterisation of the RANTES/MIP-1α receptor (CC CKR1) stably transfected in HEK 293 cells and the recombinant ligands. FEBS Lett. 376:19.
29. Rollins, B. J. 1997. Chemokines. Blood 90:909.
30. Alam, R., J. York, M. Boyars, S. Stafford, J. A. Grant, J. Lee, P. Forsythe, T. Sim, and N. Ida. 1996. Increased MCP-1, RANTES, and MIP-1α in bronchoalveolar lavage fluid of allergic asthmatic patients. Am. J. Crit. Care Med. 153:1398.
31. Cruickshank, W. W., A. Long, R. E. Tarpy, H. Kornfeld, M. P. Carroll, L. Teran, S. T. Holgate, and D. M. Center. 1995. Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1α (MIP-1α) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am. J. Respir. Cell Mol. Biol. 13:738.
32. Ebisawa, M., T. Yamada, C. Bickel, D. Klunk, and R. P. Schleimer. 1994. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J. Immunol. 153:2153.
33. Rot, A., M. Krieger, T. Brunner, S. C. Bischoff, T. J. Schall, and C. A. Dahinden. 1992. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176:1489.
34. Heath, H., S. Qin, P. Rao, L. Wu, G. LaRosa, N. Kassam, P. D. Ponath, and C. R. Mackay. 1997. Chemokine receptor usage by eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99:178.
35. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
36. Finger, E. B., R. E. Bruehl, D. F. Bainton, and T. A. Springer. 1996. A differential role for cell shape in neutrophil tethering and rolling on endothelial selectins under flow. J. Immunol. 157:5085.
37. del Pozo, M. A., P. Sanchez-Mateos, M. Nieto, and F. Sánchez-Madrid. 1995. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix: involvement of cAMP signaling pathway. J. Cell Biol. 131:495.
38. Haston, W. S., and A. F. Maggs. 1990. Evidence for membrane differentiation in polarised leucocytes: the distribution of surface antigens analysed with Ig-gold labelling. J. Cell Sci. 95:471.
39. Haslett, C., L. A. Guthrie, M. M. Kopaniak, R. B. Johnston, Jr., and P. M. Henson. 1985. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am. J. Pathol. 119:101.
40. Sabroe, I., T. J. Williams, C. A. Hébert, and P. D. Collins. 1997. Chemoattractant cross-desensitization of the human neutrophil 1L-8 receptor involves receptor intenalization and differential receptor subtype regulation. J. Immunol. 158:1361.
41. Hansell, T. T., J. D. Pound, D. Pilling, G. D. Kitas, M. Salmon, T. A. Gentle, S. S. Lee, and R. A. Thompson. 1989. Purification of human blood eosinophils by negative selection using immunomagnetic beads. J. Immunol. Methods 122:97.
42. Sehmi, R., A. J. Wardlaw, O. Cromwell, K. Kurihara, P. Waltraann, and A. B. Kay. 1992. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 79:2952.
43. Donabedian, H., T. Sawyer, and D. Senitzer. 1987. Inhibition of neutrophil shape change by an inhibitor of chemotaxis. J. Leukocyte Biol. 42:510.
44. Cole, A. T., N. M. Garlick, A. M. Galvin, C. J. Hawkey, and R. A. Robins. 1995. A flow cytometric method to measure shape change of human neutrophils. Clin. Sci. 89:549.
45. Keller, H. U., A. Fedier, and R. Rohner. 1995. Relationship between light scattering in flow cytometry and changes in shape, volume, and actin polymerization in human polymorphonuclear leukocytes. J. Leukocyte Biol. 58:519.
46. Kernen, P., M. P. Wymann, V. von Tscharner, D. A. Deranleau, P.-C. Tai, C. J. Spry, C. A. Dahinden, and M. Baggiolini. 1991. Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils. J. Clin. Invest. 87:2012.
47. Coates, T. D., R. G. Watts, R. Hartmann, and T. H. Howard. 1992. Relationship of F-actin distribution to development of polar shape in human polymorphonuclear neutrophils. J. Cell Biol. 117:765.
48. Howard, T. H., and C. O. Oresajo. 1985. The kinetics of chemotactic peptide-induced change in F-actin content. F-actin distribution, and the shape of neutrophils. J. Cell Biol. 101:1078.
49. 2+ -mobilization, actin reorganization, and GD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. Blood 88:3195.
50. Cooper, J. A. 1987. Effects of cytochalasin and pnalloidin on actin. J. Cell Biol. 105:1473.
51. Weil, G. J., and T. M. Chused. 1981. Eosinophil autofluorescence and its use in isolation and analysis of human eosinophils using flow microfluorometry. Blood 57:1099.
52. Premont, R. T., J. Inglese, and R. J. Lefkowitz. 1995. Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 6:175.
53. Richardson, R. M., H. Ali, E. D. Tomhave, B. Haribabu, and R. Snyderman. 1995. Cross-desensitization of chemoattractant receptors occurs at multiple levels. J. Biol. Chem. 270:27829.
54. 2-adrenergic receptor. Nature 383:447.
55. al-Aoukaty, A., T. J. Schall, and A. A. Maghazachi. 1996. Differential coupling of CC chemokine receptors to multiple heterotrimeric G proteins in human interleukin-2-activated natural killer cells. Blood 57:4255.